Avience Biomedicals Ltd
Open
NSE SME
SME
Closes 22 Jun 2026
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
82,200
|
— | ₹1.71 |
|
QIB
|
0.03x
|
273,600
|
— | ₹5.69 |
|
NII / HNI
|
Over 66.36x
|
207,000
|
— | ₹4.31 |
|
Retail
|
Over 58.97x
|
481,200
|
— | ₹10.01 |
| Total | 43.79x | 961,800 |
100% | ₹20.01 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 273,600 | ₹5.69 |
28.45%
|
| Market Maker | 82,200 | ₹1.71 |
8.55%
|
| NII | 207,000 | ₹4.31 |
21.52%
|
| Retail | 481,200 | ₹10.01 |
50.03%
|
| Total | 961,800 | ₹20.01 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 207,000 | 481,200 | 688,200 |
| Allotment price (₹) | 208 | 208 | 208 | 208 | 208 | 208 | 208 | 208 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹10.01 | ₹10.01 |
| Times subscribed | 0.03x | — | — | — | — | 66.36x | 58.97x | 43.79x |
| Shares allotted | — | — | — | — | — | 207,000 | 481,200 | 688,200 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 1,200 | ₹249,600 |
| Retail (Max — 13 Lots) | 13 | 7,800 | ₹1,622,400 |
| S-HNI (Min — 14 Lots) | 14 | 8,400 | ₹1,747,200 |
| B-HNI (Min — 68 Lots) | 68 | 40,800 | ₹8,486,400 |
Avience Biomedicals Ltd is proposing an IPO on NSE SME under the SME category. Total issue: 14,53,800 shares (agg. up to ₹30 Cr).
Opens 18 Jun 2026, closes 22 Jun 2026. Listing: 25 Jun 2026. Apply via ASBA or UPI.
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 29.54 | 16.64 | 10.93 |
| EBITDA | 7.65 | 3.15 | 1.43 |
| Profit After Tax (PAT) | 5.19 | 1.99 | 0.78 |
| Net Worth | 20.60 | 6.07 | 4.08 |
| Total Assets | 43.60 | 25.63 | 10.02 |
| Reserves & Surplus | 16.57 | 2.79 | 0.79 |
| Borrowings | 13.75 | 7.73 | 2.66 |
| EBITDA Margin (%) | 24.70 | — | — |
| PAT Margin (%) | 15.86 | — | — |
Avience Biomedicals Ltd IPO is subscribed 43.79 times by Jun 22, 2026. Retail: 58.97x. QIB: 0.03x. NII: 66.36x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 0.03x |
| Non Institutional (NII/HNI) | 66.36x |
| Retail Individual | 58.97x |
| Total Subscription | 43.79x |
The Avience Biomedicals Ltd IPO retail category is subscribed 58.97 times as of 22 Jun 2026. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 18 Jun 2026 and closes 22 Jun 2026. Min investment: ₹124,800 (1 lot = 600 shares). UPI mandate: 5:00 PM on 22 Jun 2026.
The Avience Biomedicals Ltd IPO subscribed 43.79x overall. QIB: 0.03x, NII: 66.36x, Retail: 58.97x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 28 Jun 2026. Refunds: on 29 Jun 2026.
The Avience Biomedicals Ltd IPO listing date is 25 Jun 2026, Thursday. Listed on: NSE SME. Issue price: ₹208. Estimated listing: ₹293. GMP: +₹85.
The Avience Biomedicals Ltd IPO closes on 22 Jun 2026, Monday. UPI mandate: 5:00 PM on 22 Jun 2026. Allotment: 28 Jun 2026. Listing: 25 Jun 2026.